Evaxion Biotech A/S

EVAX

US29970R1059

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2023-11-30 pm EST			5-day change	1st Jan Change
0.7990 ^USD	+2.44%		-0.13%	-54.99%

Nov. 30	European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading	MT
Nov. 24	European Equities Traded in the US as American Depositary Receipts Climb Higher Friday	MT

This article is reserved for members

To unlock the article, REGISTER!

100% Free Registration

Already a customer? Log In

Latest news about Evaxion Biotech A/S

European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading	Nov. 30	MT
European Equities Traded in the US as American Depositary Receipts Climb Higher Friday	Nov. 24	MT
European Equities Traded in the US as American Depositary Receipts Trend Slightly Lower in Tuesday Trading	Nov. 21	MT
European Equities Traded in the US as American Depositary Receipts Rise Sharply Friday, Up 2.7% for Week	Nov. 17	MT
European Equities Traded in the US as American Depositary Receipts Steady in Thursday Trading	Nov. 16	MT
Travel, Pharma Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher Tuesday	Nov. 14	MT
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading	Nov. 13	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday	Nov. 10	MT
ADRs End Lower; Evaxion Biotech A/S Declines 30%	Nov. 09	DJ
Oil Stocks Buoy European Equities Traded in the US as American Depositary Receipts Thursday	Nov. 09	MT
Transcript : Evaxion Biotech A/S - Special Call	Nov. 08	CI
European Equities Traded in the US as American Depositary Receipts Edge Higher in Wednesday Trading	Nov. 08	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday; Set to End Week Up 2.5%	Nov. 03	MT
European Equities Traded in the US as American Depositary Receipts Sharply Higher Thursday	Nov. 02	MT
ADRs Hold Steady; Fresh2 Group Climbs 23%	Oct. 31	DJ
Evaxion Biotech Says Cancer Vaccine Candidate Reduced Tumor in Phase 2 Study; Shares Rise	Oct. 31	MT
Evaxion Biotech A/S Announces Encouraging Initial Phase 2 Clinical Data on its Personalised Cancer Vaccine EVX-01	Oct. 31	CI
European Equities Traded in the US as American Depositary Receipts Remain Relatively Flat in Tuesday Trading	Oct. 31	MT
ADRs End Higher; TC Biopharm PLC Climbs 19%	Oct. 30	DJ
European Equities Traded in the US as American Depositary Receipts Open Week Sharply Higher Monday	Oct. 30	MT
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading	Oct. 27	MT
ADRs Close Lower; Leju Holdings Declines 29%	Oct. 26	DJ
European Equities Traded in the US as American Depositary Receipts Trend Lower Thursday	Oct. 26	MT
New and Exciting Clinical Data on Evaxion's Ai-Immunology??-Based Personalized Cancer Vaccines to Be Presented	Oct. 26	CI
European Equities Traded in the US as American Depositary Receipts Rebound Wednesday After Slow Start	Oct. 25	MT

Evaxion Biotech A/S is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

Sector

Biotechnology & Medical Research

Calendar

2023-12-09 - American Society of Hematology Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Evaxion Biotech A/S

Trading Rating :

Investor Rating :

ESG Refinitiv :

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.7990USD

Average target price

9.667USD

Spread / Average Target

+1,109.85%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
EVAXION BIOTECH A/S	-54.99%	22 M $
SEAGEN INC.	+65.91%	40 283 M $
IQVIA HOLDINGS INC.	+4.50%	39 020 M $
MODERNA, INC.	-56.74%	30 125 M $
LONZA GROUP AG	-25.31%	28 999 M $
ICON PUBLIC LIMITED COMPANY	+37.42%	21 980 M $
ALNYLAM PHARMACEUTICALS, INC.	-29.20%	20 582 M $
CELLTRION, INC.	+1.50%	17 372 M $
UNITED THERAPEUTICS CORPORATION	-13.70%	10 906 M $
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-9.55%	10 111 M $